ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0

CUSIP: 014339AA3

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Debt / NOTE 2.500% 2/0
Market price (% of par)
92.94%
Total 13F principal
$281,357,800
Principal change
+$1,335,800
Total reported market value
$269,582,510
Number of holders
27
Value change
+$6,383,357
Number of buys
12
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 014339AA3?
CUSIP 014339AA3 identifies 014339AA3 - ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 as of Q2 2019

As of 30 Jun 2019, ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 was held by 27 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $281,357,800 in principal (par value) of the bond. The largest 10 bondholders included Lion Point Capital, LP, CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, Redmile Group, LLC, UBS ASSET MANAGEMENT AMERICAS INC, Allianz Asset Management GmbH, AMERIPRISE FINANCIAL INC, AMUNDI PIONEER ASSET MANAGEMENT INC, CAPSTONE INVESTMENT ADVISORS, LLC, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 27 institutional bondholders reporting positions for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.